Med-spas are evolving into longevity clinics as GLP-1 users and wellness consumers seek regenerative treatments.
Anti-obesity medications like GLP-1s have the potential to significantly reduce mortality in countries across the globe, per a new report.
The Health & Fitness Association has praised the expansion of Medicare to cover GLP-1 drugs and calls for the coverage of exercise programs.
New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
Functional fitness brand Pvolve is contributing to the increased strength training demand, longevity movement and GLP-1 boom all at once
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
Signos wins FDA clearance for first OTC glucose monitor for weight management, combining Dexcom’s Stelo with AI-driven health insights.
Evolt is shifting the focus from weight loss to muscle mass in fitness and other related fields through new findings
Sign Up to Our Newsletter
